2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Saturday, October 6, 2018

1:45pm-3:15pm: Effects of progressive resistance and flexibility exercise program of trunk on static and dynamic stability for Parkinson’s disease

M. Lee, C. Youm, M. Son, H. Park, Y. Kim (Busan, Republic of Korea)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of Rock Steady Boxing on Activities of Daily Living and Motor Symptoms of Parkinson’s Disease

D. Larson, D. Bega, E. Johnson, L. Slowey (Chicago, IL, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of rTMS on three cortical areas in Parkinson’s Disease

V. Goyal, P. Bhat, C. Goyal, A. Srivastava, S. Kumaran, M. Behari, S. Dwivedi (Delhi, India)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Effects of the Lee Silverman Voice Treatment (LSVT LOUD ®) on Facial Expressivity in Individuals with Parkinson’s Disease (PD) as a function of Emotional Valence

A. Bono, K. Scorpio, R. Stafford, M. Halfacre, E. Murray, J. Twaite, K. Alterescu, J. Spielman, A. Halpern, L. Ramig, J. Borod (Flushing, NY, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Efficacy and safety of combined unilateral subthalamic nucleus and contralateral globus pallidus deep brain stimulation in Parkinson’s disease

N.R. Choi, K.W. Park, H.S. Ryu, M.S. Kim, S.J. Chung (Seoul, Republic of Korea)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: Efficacy and safety of Rasagiline in treatment of gait disturbances in dementia with Lewy bodies

A. Chimagomedova, O. Levin, M. Anikina, I. Ayzenberg (Moscow, Russian Federation)

Cognitive Disorders · Hall 3FG

1:45pm-3:15pm: Efficacy and safety of safinamide as a levodopa adjunct in patients with parkinson disease and motor fluctuations: A systematic review of randomized controlled trials

S. Hussain, A. Najmi (New Delhi, India)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Efficacy and security starting safinamide treatment with 100 mg/day in PD

N. Foncea (Galdakao, Spain)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Efficacy of combined treatment with acupunture and bee venom acupuncture for Parkinson’s disease: Double blind randomized controlled trial

S.U. Park, H.M. Lee, S.Y. Cho, J.M. Park, C.N. Ko (Seoul, Republic of Korea)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: Efficacy of CVT-301 (levodopa inhalation powder) for treatment of OFF periods in Parkinson’s disease

R. Pahwa, I. Abeynayake, M. Klingler, A. Sedkov, C. Kenney, C. Oh (Overland Park, KS, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG